See more : OXYGENTA PHARMACEUTICAL LIMITE (OXYGENTAPH.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Good Resources Holdings Limited (0109.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Good Resources Holdings Limited, a leading company in the Asset Management industry within the Financial Services sector.
- iShares BM&FBovespa Small Cap Fundo de Índice (SMAL11.SA) Income Statement Analysis – Financial Results
- Network Media Group Inc. (NETWF) Income Statement Analysis – Financial Results
- Airan Limited (AIRAN.NS) Income Statement Analysis – Financial Results
- Wipro Limited (WIT) Income Statement Analysis – Financial Results
- Bionano Genomics, Inc. (BNGO) Income Statement Analysis – Financial Results
Good Resources Holdings Limited (0109.HK)
About Good Resources Holdings Limited
Good Resources Holdings Limited provides financial services in Hong Kong, the People's Republic of China, and Myanmar. The company offers money lending, loan financing, financial leasing, and commercial factoring services. The company was formerly known as Good Fellow Resources Holdings Limited and changed its name to Good Resources Holdings Limited in June 2015. Good Resources Holdings Limited is based in Central, Hong Kong.
| Metric | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 113.33M | 146.48M | 145.28M | 148.51M | 45.97M | 49.05M | 124.77M | 34.32M | 32.85M | 11.76M | -26.39M | 6.46M | 3.89M | 193.00K |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -5.22M | 8.32M | 82.00K | 23.91M | 1.46M | 0.00 | 1.63M | 4.61M | 2.75M | 163.00K |
| Gross Profit | 113.33M | 146.48M | 145.28M | 148.51M | 51.19M | 40.73M | 124.69M | 10.41M | 31.40M | 11.76M | -28.02M | 1.84M | 1.14M | 30.00K |
| Gross Profit Ratio | 100.00% | 100.00% | 100.00% | 100.00% | 111.35% | 83.05% | 99.93% | 30.33% | 95.56% | 100.00% | 106.18% | 28.54% | 29.40% | 15.54% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 23.60M | 52.41M | 58.40M | 124.69M | 24.50M | 23.43M | 16.40M | 17.80M | 16.97M | 32.45M | 15.30M | 23.71M | 7.94M | 7.14M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 276.00K | 437.00K | 543.00K | 6.00K |
| SG&A | 23.60M | 52.41M | 58.40M | 124.69M | 24.50M | 23.43M | 16.40M | 17.80M | 16.97M | 32.45M | 15.58M | 24.14M | 8.49M | 7.15M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 82.00K | 0.00 | 19.48M | -23.44M | 0.00 | 0.00 | -7.27M | 3.69M |
| Operating Expenses | 23.60M | 52.41M | 58.40M | 124.69M | 24.50M | 23.43M | 16.48M | 17.80M | 36.46M | 9.01M | 15.58M | 24.14M | 1.22M | 10.84M |
| Cost & Expenses | 23.60M | 47.50M | 57.75M | 124.69M | 24.26M | 23.43M | 16.57M | 41.72M | 37.91M | 9.01M | 17.21M | 28.76M | 3.97M | 11.00M |
| Interest Income | 119.81M | 129.61M | 155.45M | 157.15M | 53.40M | 42.03M | 29.80M | 4.08M | 3.78M | 3.96M | 1.24M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 2.00K | 0.00 | 0.00 | 1.99M | 4.22M | 0.00 | 32.00K | 4.08M | 3.78M | 3.96M | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 10.49M | 10.40M | 6.02M | 5.94M | 261.00K | 178.00K | 331.00K | 316.00K | 316.00K | 330.00K | 303.00K | 271.00K | 145.00K | 150.00K |
| EBITDA | 91.79M | 112.12M | 106.42M | 26.91M | 25.95M | 25.80M | 108.18M | -585.63M | 475.50M | 1.28M | -44.06M | -42.12M | 248.00K | -13.65M |
| EBITDA Ratio | 80.99% | 76.54% | 73.25% | 18.12% | 56.44% | 52.59% | 86.70% | -1,706.32% | 1,447.35% | 10.87% | 166.96% | -652.50% | 6.37% | -7,071.50% |
| Operating Income | 81.30M | -47.50M | -57.75M | 20.46M | 26.94M | 17.30M | 2.61M | -7.40M | -5.06M | 2.75M | -43.60M | -22.30M | -74.00K | -10.81M |
| Operating Income Ratio | 71.74% | -32.43% | -39.75% | 13.78% | 58.59% | 35.28% | 2.09% | -21.55% | -15.40% | 23.37% | 165.21% | -345.47% | -1.90% | -5,598.96% |
| Total Other Income/Expenses | -1.59M | 138.73M | 149.86M | -9.52M | -5.47M | 8.32M | 105.20M | -582.63M | 476.46M | -5.76M | -765.00K | -20.09M | 0.00 | 0.00 |
| Income Before Tax | 79.71M | 91.24M | 92.12M | 10.94M | 21.47M | 25.62M | 107.81M | -590.02M | 471.40M | -3.01M | -44.37M | -42.39M | 0.00 | 0.00 |
| Income Before Tax Ratio | 70.33% | 62.29% | 63.41% | 7.36% | 46.70% | 52.23% | 86.41% | -1,719.12% | 1,434.88% | -25.60% | 168.11% | -656.70% | 0.00% | 0.00% |
| Income Tax Expense | 27.18M | 27.35M | 25.22M | 35.14M | 8.30M | 5.69M | 3.57M | 29.29M | -510.00K | -520.00K | -765.00K | -20.09M | 0.00 | 0.00 |
| Net Income | 54.12M | 74.37M | 75.18M | -16.16M | 13.17M | 19.92M | 104.24M | -619.31M | 471.91M | -2.49M | -44.37M | -42.39M | 103.00K | -13.80M |
| Net Income Ratio | 47.75% | 50.77% | 51.75% | -10.88% | 28.64% | 40.62% | 83.54% | -1,804.47% | 1,436.43% | -21.18% | 168.11% | -656.70% | 2.65% | -7,149.22% |
| EPS | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.07 | -0.43 | 0.33 | 0.00 | -0.06 | -0.07 | 0.00 | 0.00 |
| EPS Diluted | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.07 | -0.43 | 0.30 | 0.00 | -0.06 | -0.07 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 7.09B | 7.12B | 7.20B | 7.06B | 1.81B | 1.44B | 1.44B | 1.44B | 1.44B | 1.31B | 718.98M | 597.67M | 3.72B | 3.44B |
| Weighted Avg Shares Out (Dil) | 7.09B | 7.12B | 7.20B | 7.06B | 1.81B | 1.44B | 1.44B | 1.44B | 1.56B | 1.31B | 718.98M | 597.67M | 3.72B | 3.44B |
Source: https://incomestatements.info
Category: Stock Reports